Journal of Healthcare Management - January/February 2013 - (Page 29)

challenges and facilitators of community clinical Oncology Program Participation: a Qualitative Study Ann Scheck McAlearney, ScD, professor and vice chair for research, Department of Family Medicine, College of Medicine, The Ohio State University, Columbus; Kristin L. Reiter, PhD, assistant professor, Department of Health Policy and Management, University of North Carolina at Chapel Hill; Bryan J. Weiner, PhD, professor, Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Lori Minasian, MD, chief, Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and Paula H. Song, PhD, assistant professor, Division of Health Services Management and Policy, College of Public Health, The Ohio State University E X E C U t i V E S U M M a r Y Successful participation in the national cancer Institute’s community clinical Oncology Program (ccOP) can expand access to clinical trials and promote cancer treatment innovations for patients and communities without access to major cancer centers. Yet ccOP participation involves administrative, financial, and organizational challenges that can affect hospital and provider participants. This study was designed to improve our understanding of challenges associated with ccOP participation from the perspectives of involved providers and to learn about opportunities to overcome these challenges. We conducted five case studies of hospitals and providers engaged with the ccOP. across organizations, we interviewed 41 key administrative, physician, and nurse informants. We asked about ccOP participation, focusing on issues related to implementation, operations, and organizational support. challenges associated with ccOP participation included lack of appreciation for the value of participation and poor understanding about ccOP operations, cost, and required workflow changes, among others. Informants also suggested opportunities to facilitate participation: (1) increase awareness of the ccOP, (2) enhance commitment to the ccOP, and (3) promote and support champions of the ccOP. Improving our understanding of the challenges and facilitators of ccOP participation may assist hospitals and providers in increasing and sustaining participation in the ccOP, thus helping to preserve access to innovative cancer treatment options for patients in need. for more information on the concepts in this article, please contact Dr. mcalearney at mcalearney.1@osu.edu. 29

Table of Contents for the Digital Edition of Journal of Healthcare Management - January/February 2013

Journal of Healthcare Management
Interview
Reform
Integrated Health Systems
Post-Acute Care and Vertical Integration After the Patient Protection and Affordable Care Act
Challenges and Facilitators of Community Clinical Oncology Program Participation: A Qualitative Study
The Application of Hospitality Elements in Hospitals
Thirty-Day Readmission Rates as a Measure of Quality: Causes of Readmission After Orthopedic Surgeries and Accuracy of Administrative Data
Abstract from the Academy of Management

Journal of Healthcare Management - January/February 2013